120 related articles for article (PubMed ID: 17630926)
1. Controlled release of the pineal hormone melatonin from hydroxypropylmethylcellulose/sodium alginate matrices in aqueous media containing dioctyl sulfosuccinate.
Vlachou M; Tsiakoulia A; Eikosipentaki A
Curr Drug Discov Technol; 2007 Jun; 4(1):31-8. PubMed ID: 17630926
[TBL] [Abstract][Full Text] [Related]
2. Pineal hormone melatonin: solubilization studies in model aqueous gastrointestinal environments.
Vlachou M; Eikosipentaki A; Xenogiorgis V
Curr Drug Deliv; 2006 Jul; 3(3):255-65. PubMed ID: 16848727
[TBL] [Abstract][Full Text] [Related]
3. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
[TBL] [Abstract][Full Text] [Related]
4. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
Tadros MI
Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
[TBL] [Abstract][Full Text] [Related]
6. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
Chavanpatil MD; Khdair A; Panyam J
Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
Nie SF; Liu H; Liu YL; Pan WS
Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
[TBL] [Abstract][Full Text] [Related]
8. Polymers for use in controlled release systems: the effect of surfactants on their swelling properties.
Vlachou M; Hani N; Efentakis M; Tarantili PA; Andreopoulos AG
J Biomater Appl; 2000 Jul; 15(1):65-77. PubMed ID: 10972160
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sodium alginate as drug release modifier in matrix tablets.
Liew CV; Chan LW; Ching AL; Heng PW
Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
[TBL] [Abstract][Full Text] [Related]
10. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets.
Velasco MV; Ford JL; Rowe P; Rajabi-Siahboomi AR
J Control Release; 1999 Jan; 57(1):75-85. PubMed ID: 9863041
[TBL] [Abstract][Full Text] [Related]
11. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
12. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
Moroni A; Drefko W; Thone G
Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
[TBL] [Abstract][Full Text] [Related]
13. Microencapsulation of lipid nanoparticles containing lipophilic drug.
Lee KE; Cho SH; Lee HB; Jeong SY; Yuk SH
J Microencapsul; 2003; 20(4):489-96. PubMed ID: 12851049
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the influencing factors on the drug release from sodium alginate matrices].
Nie SF; Wu XM; Liu HF; Jiang HW; Pan WS
Yao Xue Xue Bao; 2004 Jul; 39(7):561-5. PubMed ID: 15493851
[TBL] [Abstract][Full Text] [Related]
15. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.
Awasthi R; Kulkarni GT
Drug Dev Ind Pharm; 2014 Mar; 40(3):398-408. PubMed ID: 23418961
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
Abd-Elbary A; Haider M; Sayed S
Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
[TBL] [Abstract][Full Text] [Related]
17. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow-release tablets containing miconazole nitrate.
Mohammed FA; Khedr H
Drug Dev Ind Pharm; 2003 Mar; 29(3):321-37. PubMed ID: 12741613
[TBL] [Abstract][Full Text] [Related]
19. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts.
Farid RM; Etman MA; Nada AH; Ebian Ael A
AAPS PharmSciTech; 2013 Jun; 14(2):712-8. PubMed ID: 23516112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
